Validity and reliability of the us national cancer institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

JAMA Oncology

Volumn 1, Issue 8, 2015, Pages 1051-1059

  Dueck, Amylou C ^a   Mendoza, Tito R ^c   Mitchell, Sandra A ^d   Reeve, Bryce B ^e   Castro, Kathleen M ^c   Rogak, Lauren J ^f   Atkinson, Thomas M ^b   Bennett, Antonia V ^e   Denicoff, Andrea M ^c   O'Mara, Ann M ^f   Li, Yuelin ^f   Clauser, Steven B ^c   Bryant, Donna M ^g   Bearden, James D ^a   Gillis, Theresa A ^a   Harness, Jay K ^h   Siegel, Robert D ⁱ   Paul, Diane B ^j   Cleeland, Charles S ^f   Schrag, Deborah ^k   Sloan, Jeff A ^l   Abernethy, Amy P ^m   Bruner, Deborah W ⁿ   Minasian, Lori M ^a   Basch, Ethan ^d   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f Cancer Program of Our Lady of the Lake and Mary Bird Perkins ^*  (United States)

^g Gibbs Cancer Center   (United States)

^h HELEN F GRAHAM CANCER CENTER   (United States)

ⁱ ST JOSEPH HOSPITAL   (United States)

^j HARTFORD HOSPITAL   (United States)

^k DANA FARBER CANCER INSTITUTE   (United States)

^l MAYO CLINIC   (United States)

^m DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁿ EMORY UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVERSE EFFECTS; AGED; AMBULATORY CARE; CHEMORADIOTHERAPY; CLASSIFICATION; CLINICAL TRIAL; DRUG SURVEILLANCE PROGRAM; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMAN; MALE; MICROCOMPUTER; MIDDLE AGED; MULTICENTER STUDY; NATIONAL HEALTH ORGANIZATION; NEOPLASMS; NOMENCLATURE; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION INJURIES; REPRODUCIBILITY; SELF REPORT; TIME; TREATMENT OUTCOME; UNITED STATES; VALIDATION STUDY; VERY ELDERLY; YOUNG ADULT;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY; COMPUTERS, HANDHELD; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY; REPRODUCIBILITY OF RESULTS; SELF REPORT; SURVEYS AND QUESTIONNAIRES; TERMINOLOGY AS TOPIC; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84965094526     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2015.2639     Document Type: Article

References (31)

1. National Cancer Institute, National Institutes of Health, US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE), Version 4.0. NIH publication 09-7473. Published May 29, 2009; Revised June 14, 2010. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14-QuickReference-5x7.pdf. Accessed March 16, 2015.
2. Setser A. CTCAE v4.0: Frequently Asked Questions. http://evs.nci.nih.gov/ftp1/CTCAE/Archive/CTCAE-4.01-2009-07-14-FAQ.doc. Accessed March 16, 2015.
3. Trotti A, Colevas AD, Setser A, Basch E. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol. 2007;25(32):5121-5127.
4. Atkinson TM, Li Y, Coffey CW, et al. Reliability of adverse symptom event reporting by clinicians. Qual Life Res. 2012;21(7):1159-1164.
5. Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med. 2010;362(10): 865-869.
6. Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? a comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol. 2004;22(17):3485-3490.
7. Pakhomov SV, Jacobsen SJ, Chute CG, Roger VL. Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care. 2008;14(8):530-539.
8. Basch E, Jia X, Heller G, et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009;101(23):1624-1632.
9. Quinten C, Maringwa J, Gotay CC, et al. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. J Natl Cancer Inst. 2011;103(24):1851-1858.
10. Meacham R, McEngart D, O'Gorman H, Wenzel K. Use and compliance with electronic patient reported outcomes within clinical drug trials. Paper presented at: 2008 ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Annual International Meeting; May 3-7, 2008; Toronto, Ontario, Canada.
11. Judson TJ, Bennett AV, Rogak LJ, et al. Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol. 2013;31(20):2580-2585.
12. Di Maio M, Gallo C, Leighl NB, et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol. 2015;33(8):910-915.
13. Basch E, Iasonos A, McDonough T, et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol. 2006;7 (11):903-909.
14. Basch EM, Reeve BB, Mitchell SA, et al. Electronic toxicity monitoring and patient-reported outcomes. Cancer J. 2011;17(4):231-234.
15. Basch E, Reeve BB, Mitchell SA, et al. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106(9):dju244.
16. Hay JL, Atkinson TM, Reeve BB, et al; NCI PRO-CTCAE Study Group. Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Qual Life Res. 2014;23(1):257-269.
17. Agarwal H, Gulati M, Baumgartner P, et al. Web interface for the patient-reported version of the CTCAE. Paper presented at: NCI caBIG Annual Meeting; July 20-22, 2009; Washington, DC.
18. Arnold BJ, Mitchell SA, Lent L, et al. Linguistic validation of the Spanish translation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events. Paper presented at: International Society for Quality of Life Research 21st Annual Conference; October 15-18, 2014; Berlin, Germany.
19. Reeve BB, Mitchell SA, Dueck AC, et al. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7):dju129.
20. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365-376.
21. Gundy CM, Fayers PM, Groenvold M, et al. Comparing higher order models for the EORTC QLQ-C30. Qual Life Res. 2012;21(9):1607-1617.
22. Kieffer JM, Giesinger JM, Fayers P, et al. Replication and relative validity of the mental and physical higher order model of the EORTC QLQ-C30. Paper presented at: International Society for Quality of Life Research 21st Annual Conference; October 15-18, 2014; Berlin, Germany.
23. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139-144.
24. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR; Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77(4):371-383.
25. Mendoza TR, Bennett AV, Mitchell SA, et al. Impact of recall period on the accuracy of selected items from the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Poster presented at: International Society for Quality of Life Research 21st Annual Conference; October 15-18, 2014; Berlin, Germany.
26. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, New Jersey: Lawrence Erlbaum Associates; 1988.
27. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979; 86(2):420-428.
28. Nunnally JC, Berstein IH. Psychometric Theory. 3rd ed. New York: McGraw-Hill; 1994.
29. Jonckheere AR. A distribution-free k-sample test against ordered alternatives. Biometrika. 1954; 41:133-145.
30. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988; 75:800-802.
31. Kirsch M, Mitchell SA, Dobbels F, et al. Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. Eur J Oncol Nurs. 2015;19(1):66-74.